Skip to content
Head to head

Alphatec vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: ATEC · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

ATEC -66.4%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (22); Abbott Laboratories has done best over the past year (-15%); Abbott Laboratories pays the highest dividend yield.
ATECABT
Snapshot
SectorMedical DevicesMedical Devices
Last price6.68103.00
Change today-3.19%-0.84%
1-year return-65.9%-15.4%
Market cap$1.04B$178.39B
52-week range6.63 – 23.2980.89 – 126.70
Valuation
P/E (TTM)-11.7238.29
P/E percentile, own 5-yr range18th99th
P/B-445.333.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-0.963.72
Net profit (TTM)$-148.93M$6.44B
Revenue (TTM)$839.72M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+12.6%+14.5%
Gross margin71.3%56.9%
Operating margin-3.0%13.8%
Net margin-10.3%9.7%
Free cash flow (TTM)$-10.44M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership87.4%81.2%
Insider activity (12mo)25 buy / 24 sell36 buy / 12 sell
Short interest (% of float)9.2%1.1%
Analyst consensus89% buy / 11% hold (9)93% buy / 7% hold (15)
Analyst price target$14 (+107%)$122 (+18%)
StockVane view
StockVane Quant RatingE (3)D (22)
Company
Employees913115,000
Founded20051900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.